Aptus Pharma IPO Will Open On Sep 23, 2025 And Close On Sep 25, 2025. The ₹13.02 Cr. IPO Is A Fresh Offer. Aptus Pharma IPO Price Band is Set At ₹65 to ₹70 Per share.
The Allotment Will Be Finalized On Sep 26, 2025 and Listing date is Expected on The BSE SME By Sep 30, 2025. Investor Quota like 47.31% Retail, and 33.33% HNI 14.30 and Market Maker is 5.05% Category.
Financial Year 2025 Company Posted a Revenue of ₹24.64 Cr. and A Net Profit of ₹3.10 Cr. Showing Strong Growth From The Previous Year. Based On Financial, The IPO Looks Promising For Long-term Investors.
Aptus Pharma IPO Dates & Price Band Details
| Open Date | Sep 23, 2025 |
|---|---|
| Close Date | Sep 25, 2025 |
| Price Band | ₹65 to ₹70 per share |
| Face Value | ₹10 per equity share |
| Lot Size | 2,000 Shares |
| Minimum Investment | ₹1,40,000 (for 1 lot at ₹70) |
| Type of Issue | Fresh Issue |
| Total Issue Size | 18,60,000 shares (Approx ₹13.02 Cr) |
| Market Maker | 94,000 shares (Approx ₹0.6580 Cr) |
| Net Offered to Public | 17,66,000 shares (Approx ₹12.36 Cr) |
| Issue Type | Bookbuilding IPO |
| Listing Exchange | BSE SME |
| Retail Investor Quota | 33.33% |
| QIB Quota | 47.31% |
| NII (HNI) Quota | 14.30% |
| Anchor Investor List | Click Here |
| DRHP (Draft Prospectus) | Click Here |
| RHP (Final Prospectus) | Click Here |
About Aptus Pharma Limited
Our Company was originally incorporated on June 11, 1999 “Aptus Pharma Limited” engaged in the business of marketing, and distribution of finished pharmaceutical formulations.
While the Company does not own any manufacturing facilities, it operates through a contract manufacturing model. We do not own any manufacturing plants but has entered into contract manufacturing agreement with seven manufacturing units. under various arrangements.
we have formal loan and license agreements in place with two manufacturing units. The remaining production is carried out through informal arrangements with Other manufacturers, based on purchase orders (PO).
We provide a diverse range of pharmaceutical products catering to various therapeutic categories including anti-infectives, gastrointestinal, antacids, anti-allergic and respiratory, nutritional supplements, pain management, neuro-psychiatric, cardiovascular, anti-diabetic, lipidlowering, and general wellness products. These are offered across a variety of dosage forms, such as tablets,capsules, softgels, syrups, suspensions, injections, ointments, creams, balms, drops, lotions, vials, powders, gels,
and sachets.
our product basket comprises of 194 pharmaceutical formulations in more than eleven (11) therapeutic segments.
We have a distribution network of more than 125 direct and Sub Distributers distributors and a sales team comprising more than 54 field personnel including Medical Representatives (MRs), Area Sales Managers (ASMs), Divisional Sales Managers (DSMs), Regional Sales Managers (RSMs), and a Zonal Manager.
Our product portfolio is structured across four distinct divisions to ensure focused marketing and efficientcoverage of therapeutic segments:
1. Aptus Pharma (Pioneer Division): Focused on acute therapies including general anti-infectives, pain management, antacids, and gastrointestinal drugs etc.
2. Aptus CD Care (Cardiac Diabetic Division): Dedicated to chronic therapies, including anti-hypertensive, anti-diabetic, and lipid-lowering.
3. Aptus Wellcare (Wellcare Division): Offers wellness and nutraceutical products, over-the-counter (OTC) formulations, and personal care products.
4. Aptus Global (Export Division): This division is focused on exploring and developing opportunities in overseas markets, particularly in semi-regulated and emerging countries.
Aptus Pharma IPO Market Lot Size
The Minimum Lot Size For The Aptus Pharma IPO is 4,000 Shares, Requiring An Application Amount of ₹1,40,000 and in multiples of 2,000 For Retail Investors. Investors Must Apply in Multiples of The Lot Size.
| Application | Lot Size | Shares | Amount |
|---|---|---|---|
| Retail Minimum | 2 | 4,000 | ₹2,80,000 |
| Retail Maximum | 2 | 4,000 | ₹2,80,000 |
| S-HNI Minimum | 3 | 6,000 | ₹4,20,000 |
| S-HNI Maxmum | 7 | 14,000 | ₹9,80,000 |
| B-HNI Minimum | 8 | 16,000 | ₹11,20,000 |
Objects Of The Issue
1. Capital Expenditure for Office Premises with furniture and Industrial Racks.
2. Working Capital.
3. General Corporate Purpose.
Aptus Pharma IPO Allotment & Listing Dates
Aptus Pharma IPO Will Open on Sep 23 and Close on Sep 25, 2025. The allotment is Expected on Sep 26, With the Listing Scheduled on BSE SME For Sep 30, 2025 (More information below table).
| Anchor Investor Bidding | Mon, Sep 22, 2025 |
|---|---|
| IPO Open | Tue, 23 Sep 2025 |
| IPO Close | Thu, 25 Sep 2025 |
| Allotment Finalisation | Fri, 26 Sep 2025 |
| Refunds / Unblocking | Mon, 29 Sep 2025 |
| Shares Credited to Demat | Mon, 29 Sep 2025 |
| Listing Date | Tue, 30 Sep 2025 |
Aptus Pharma IPO Financial Report (FY 2025)
Aptus Pharma Reported a total Revenue of ₹24.64 Cr. in FY 2025, Slightly up From ₹17.88 Cr. in FY 2024. The Company Net Profit Also Rose to ₹3.10 Cr. From ₹0.80 Cr. in the Previous Year Showing Consistent Financial Growth Ahead of its IPO. (More information below table).
| Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Assets (Total) | 21.92 | 10.03 | 6.22 |
| Revenue | 24.64 | 17.88 | 13.90 |
| Profit After Tax | 3.10 | 0.80 | 0.19 |
| EBITDA | 4.76 | 1.49 | 0.57 |
| Net Worth | 6.97 | 1.77 | 0.97 |
| Reserves and Surplus | 1.97 | 1.47 | 0.67 |
| Total Borrowing | 10.36 | 5.31 | 2.21 |
| (₹ Million) |
Aptus Pharma IPO Valuation Report – FY 2025 (KPI)
Check Detailed Aptus Pharma IPO Valuation Metrics for FY 2025, including EPS, P/E Ratio, RoNW, NAV, ROCE, and other key financial indicators. These Ratios help Investors Assess the Company financial Health & Valuation Before applying for The IPO. (More information below table).
| KPI | Value |
|---|---|
| Return on Equity (ROE) | 44.50% |
| Return on Capital Employed (ROCE) | 45.66% |
| EBITDA Margin | 19.31% |
| Debt-to-Equity Ratio | 1.49 |
| Earnings Per Share (EPS) | 6.20 |
| Price to Earnings Ratio (P/E) | 11.29 |
| Return on Net Worth (RoNW) | 44.50% |
| Net Asset Value (NAV) | 13.93 |
Our Competitive Strengths
Diversified customer base and long-standing relationship with our customers.
Efficient Supplier network.
Wide Geographic presence.
Experienced Promoter Directors with extensive domain knowledge.
Track record of delivering growth and profitability.
Our Company Promoters
- Mr. Tejash Maheshchandra Hathi
- Mrs. Milly Chetan Lalseta
- Mr. Riddhish Natwarlal Tanna
- Mr. Kapilbhai Hasmukhbhai Chandarana
- Mr. Ghanshyam Vinubhai Pansuriya
- Mr. Chatrabhuj Vallabhbhai Butani
- Mr. Gaurang Rameshchandra Thakker
- Mrs. Kripaliben Mayank Thakker
- Mrs. Kunjal Piyush Unadkat,
Comparison of Accounting Ratios with Industry Peers
| Company | Face value (₹) | CMP Sep 11, 2025 (₹) | EPS ) (₹) | P/E | (“RoNW”) (%) | NAV Price (₹) | Revenue 2025 (₹ million) |
|---|---|---|---|---|---|---|---|
| Aptus Pharma Limited | 10 | [.] | 5.32 | - | 44.50 | 13.93 | 2,455.77 |
| Zota health care limited | 10 | 1,207.50 | 3.16 | 382.12 | 2.72 | 110.83 | 25,727.61 |
| Sunrest Lifescience Limited | 10 | 49.20 | 4.66 | 10.56 | 12.36 | 37.72 | 3,312.24 |
| Lincoln Pharmaceuticals Limited | 10 | 556.10 | 41.11 | 13.53 | 12.36 | 335.34 | 62,323.01 |
Also Read: Aptus Pharma IPO GMP Today, Grey Market Premium Live
Aptus Pharma Company Contact Details
Corporate Office: SHREE Building 1st Floor
Opp Satyasai Heart Hospital,
Narayan Nagar Kalawad Road,
Rajkot Sau Uni Area Rajkot, Gujarat, 360005
Telephone: +91 76004 27827
Email: info@aptuspharma.com
Website: www.aptus-pharma.com
Aptus Pharma Lead Manager
INTERACTIVE FINANCIAL SERVICES LIMITED
Address: Office No. 508,
Fifth Floor, Priviera,Nehru Nagar,
Ahmedabad – 380 015, Gujarat, India
Tel No.: 079 4908 8019
Email: mbd@ifinservices.in
Website: www.ifinservices.in
Aptus Pharma IPO Registrar
BIGSHARE SERVICES PRIVATE LIMITED
Address: Office No. S6-2, 6th Floor,
Pinnacle Business Park, Next to Ahura
Centre, Mahakali Caves Road,
Andheri (East), Mumbai – 400093
Telephone: 022-62638200
Email: ipo@bigshareonline.com
Website: www.bigshareonline.com
Aptus Pharma IPO FAQs
Question 1: What is the Aptus Pharma IPO?
Answer 1:Aptus Pharma IPO is a SME IPO of 18,60,000 equity shares of the face value of ₹10 approximately up to ₹13.02 Cr. The issue is priced at ₹65 to ₹70 per share.
The Aptus Pharma IPO opens on Sep 23, 2025 and closes on Sep 25, 2025.
BIGSHARE SERVICES PRIVATE LIMITED is the registrar for the IPO. The shares to be listed on BSE SME.
Question 2: How to apply in Aptus Pharma IPO through Groww?
Answer 2: Groww customers can apply online in Aptus Pharma IPO using UPI as a payment gateway. Groww customers can apply in Aptus Pharma IPO by login into Groww (back office) and submitting an IPO application form.
Steps to apply in Aptus Pharma IPO through Groww –
- Visit the Groww website and login to Groww.
- Go to Main Page and click the Products & tools and click IPO tab.
- New page Open and Show ‘Aptus Pharma IPO’ click the ‘Apply’ button.
- Show IPO detail Shares lot Size and Bid Price & click here to Cutoff Price check Box and Continue.
- Inter Your UPI id like . 95****299@kotak accept terms and condition click Box and Apply For IPO
- groww share payment link Your UPI Mobile Number Pay Payment for IPO Bid to approve the e-mandate successfully submit application .
Question 3: When Aptus Pharma IPO will open?
Answer 3: The Aptus Pharma IPO opens on Sep 23, 2025, and closes on Sep 25, 2025.
Question 4: What is the lot size of Aptus Pharma IPO?
Answer 4:Aptus Pharma IPO lot size and the minimum order quantity is 2,000 Shares.
Question 5: How to apply for Aptus Pharma IPO?
Answer 5: You can apply in Aptus Pharma IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don’t offer banking services. Read more detail about applying IPO online through Groww, Zerodha, Upstox, 5Paisa, Phonepe Share Market, HDFC Bank, and Angel one.
Question 6: When is Aptus Pharma IPO allotment date?
Answer 6: The Basis of Allotment for Aptus Pharma IPO will be on Fri, Sept 26, 2025, and the allotted shares will be credited to your demat account by Mon, Sep 29, 2025. For Check the Aptus Pharma IPO allotment status.
Question 7: When is Aptus Pharma IPO listing date?
Answer 7: The Aptus Pharma IPO listing date is Sep 30, 2025. The date of Aptus Pharma IPO listing on Tue, Sep 30, 2025.
